News

Hundreds of people with cystic fibrosis in England will now have access to a new once-daily triple therapy, expanding treatment to rare genetic types for the first time.

Learn how visual training improves radiology accuracy and efficiency, with peripheral focus proving more impactful than central vision methods.

Scientists have identified a rare and previously overlooked type of circulating tumour cell (CTC) in patients with metastatic breast cancer…

Dapagliflozin reverses myocardial fibrosis in HFpEF with diabetes, suggesting a disease-modifying effect.

Peanut oral immunotherapy (POIT), which involves gradually increasing exposure to peanut protein, has shown promise, successfully desensitising 50–70% of patients.

Discover a study revealing how subclinical liver fibrosis, measured by FIB-4, predicts increased mortality risk in coronary artery disease patients.

Semaglutide and tirzepatide lower risks of dementia, stroke, and death in type 2 diabetes and obesity, new study shows.

UK Biobank’s massive imaging project scans 100,000 people to reveal early disease signs, transforming diagnosis and prevention worldwide.